24.04.2018 22:01:00

Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference

NEW BRUNSWICK, N.J., April 24, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference on Wednesday, May 9th, at The InterContinental Boston.  Mathai Mammen, MD, Ph.D., Global Head, Research & Development, Janssen Research and Development will represent the Company in a session scheduled at 9:20 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

 (PRNewsfoto/Johnson & Johnson)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-2018-deutsche-bank-43rd-annual-health-care-conference-300635765.html

SOURCE Johnson & Johnson

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,26 0,32% Johnson & Johnson